Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, September 2009, p. 4040-4042, Vol. 53, No. 9
0066-4804/09/$08.00+0 doi:10.1128/AAC.00312-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Department of Specific Prophylaxis and Tropical Medicine, Medical University of Vienna, Vienna, Austria,1 MARIB, Malaria Research Initiative Bandarban, Bandarban, Bangladesh,2 International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh3
Received 6 March 2009/ Returned for modification 17 May 2009/ Accepted 3 July 2009
Tigecycline is a novel glycylcycline antibiotic with a broad antibacterial spectrum. Tigecycline was tested with 66 clinical isolates of Plasmodium falciparum from Bangladesh using the histidine-rich protein 2 in vitro drug susceptibility assay. The 50% and 90% inhibitory concentrations of tigecycline were 699 (95% confidence interval, 496 to 986) and 5,905 nM (4,344 to 8,028). Tigecycline shows no activity correlation with traditional antimalarials and has substantial antimalarial activity on its own.
Published ahead of print on 13 July 2009.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»